Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Nasal flap or cutaneous grafting in basal cell cancer of the nose. Comparison of two reconstructive possibilities.

Vergine M, Frusone F, De Luca A, Aceti V, Marcasciano M, Amabile MI, Monti M.

G Chir. 2019 Jul-Aug;40(4):298-303.

PMID:
32011980
2.

α-lipoic acid in patients with autosomal dominant polycystic kidney disease.

Lai S, Petramala L, Muscaritoli M, Cianci R, Mazzaferro S, Mitterhofer AP, Pasquali M, D'Ambrosio V, Carta M, Ansuini M, Ramaccini C, Galani A, Amabile MI, Molfino A, Letizia C.

Nutrition. 2020 Mar;71:110594. doi: 10.1016/j.nut.2019.110594. Epub 2019 Sep 27.

PMID:
31790890
3.

Abductor muscle strengthening in THA patients operated with minimally invasive anterolateral approach for developmental hip dysplasia.

Benedetti MG, Cavazzuti L, Amabile M, Tassinari E, Valente G, Zanotti G, Vaienti E, Orsini S, Mariani E, Taddei F.

Hip Int. 2019 Sep 22:1120700019877174. doi: 10.1177/1120700019877174. [Epub ahead of print]

PMID:
31544524
4.

Patient-reported outcome measures (PROMs) after elective hip, knee and shoulder arthroplasty: protocol for a prospective cohort study.

Grassi A, Golinelli D, Tedesco D, Rolli M, Bordini B, Amabile M, Rucci P, Fantini MP, Zaffagnini S.

BMC Musculoskelet Disord. 2019 Aug 15;20(1):374. doi: 10.1186/s12891-019-2745-3.

5.

Cytological features of breast implant-associated anaplastic large cell lymphoma in pleural effusion.

D'Alessandris N, Lucatelli P, Tripodi D, Amabile MI, Ascoli V.

Diagn Cytopathol. 2019 Nov;47(11):1213-1217. doi: 10.1002/dc.24287. Epub 2019 Jul 26.

PMID:
31348611
6.

Investigational drugs for the treatment of cancer cachexia: a focus on phase I and phase II clinical trials.

Molfino A, Amabile MI, Giorgi A, Monti M, D'Andrea V, Muscaritoli M.

Expert Opin Investig Drugs. 2019 Aug;28(8):733-740. doi: 10.1080/13543784.2019.1646727. Epub 2019 Jul 26. Review.

PMID:
31347405
7.

Squeaking and other noises in patients with ceramic-on-ceramic total hip arthroplasty.

Baruffaldi F, Mecca R, Stea S, Beraudi A, Bordini B, Amabile M, Sudanese A, Toni A.

Hip Int. 2019 Jul 21:1120700019864233. doi: 10.1177/1120700019864233. [Epub ahead of print]

PMID:
31328560
8.

Longitudinal Physical Activity Change During Hemodialysis and Its Association With Body Composition and Plasma BAIBA Levels.

Molfino A, Amabile MI, Ammann T, Lai S, Grosso A, Lionetto L, Spagnoli A, Simmaco M, Monti M, Laviano A, Chiappini MG, Muscaritoli M.

Front Physiol. 2019 Jun 25;10:805. doi: 10.3389/fphys.2019.00805. eCollection 2019.

9.

Breast Cancer and Multiple Primary Malignant Tumors: Case Report and Review of the Literature.

De Luca A, Frusone F, Vergine M, Cocchiara R, La Torre G, Ballesio L, Monti M, Amabile MI.

In Vivo. 2019 Jul-Aug;33(4):1313-1324. doi: 10.21873/invivo.11605. Review.

10.

Ischemia-Modified Albumin Expression: Is there a Difference between Male and Female Subjects?

Stea S, Pasquale D, Beraudi A, Catalani S, Amabile M, Bracci G, Toni A.

Clin Lab. 2019 Jun 1;65(6). doi: 10.7754/Clin.Lab.2018.180811.

PMID:
31232020
11.

DHA Oral Supplementation Modulates Serum Epoxydocosapentaenoic Acid (EDP) Levels in Breast Cancer Patients.

Molfino A, Amabile MI, Lionetto L, Spagnoli A, Ramaccini C, De Luca A, Simmaco M, Monti M, Muscaritoli M.

Oxid Med Cell Longev. 2019 Mar 5;2019:1280987. doi: 10.1155/2019/1280987. eCollection 2019.

12.

PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications.

Ulisse S, Tuccilli C, Sorrenti S, Antonelli A, Fallahi P, D'Armiento E, Catania A, Tartaglia F, Amabile MI, Giacomelli L, Metere A, Cornacchini N, Pironi D, Carbotta G, Vergine M, Monti M, Baldini E.

Int J Mol Sci. 2019 Mar 20;20(6). pii: E1405. doi: 10.3390/ijms20061405. Review.

13.

Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy.

Lai S, Muscaritoli M, Andreozzi P, Sgreccia A, De Leo S, Mazzaferro S, Mitterhofer AP, Pasquali M, Protopapa P, Spagnoli A, Amabile MI, Molfino A.

Nutrition. 2019 Jun;62:108-114. doi: 10.1016/j.nut.2018.12.005. Epub 2018 Dec 11.

PMID:
30875540
14.

Nutrition support for treating cancer-associated weight loss: an update.

Molfino A, Amabile MI, Muscaritoli M.

Curr Opin Support Palliat Care. 2018 Dec;12(4):434-438. doi: 10.1097/SPC.0000000000000383. Review.

PMID:
30382948
15.

Peritoneal dialysis in older adults: Evaluation of clinical, nutritional, metabolic outcomes, and quality of life.

Lai S, Amabile MI, Bargagli MB, Musto TG, Martinez A, Testorio M, Mastroluca D, Lai C, Aceto P, Molfino A; Study Group on Geriatric Nephrology of the Italian Society of Nephrology (SIN).

Medicine (Baltimore). 2018 Aug;97(35):e11953. doi: 10.1097/MD.0000000000011953.

16.

Morphological and Semiquantitative Kinetic Analysis on Dynamic Contrast Enhanced MRI in Triple Negative Breast Cancer Patients.

Gigli S, Amabile MI, David E, De Luca A, Grippo C, Manganaro L, Monti M, Ballesio L.

Acad Radiol. 2019 May;26(5):620-625. doi: 10.1016/j.acra.2018.06.014. Epub 2018 Aug 23.

PMID:
30145205
17.

PTEN expression and its association with glucose control and calorie supplementation in critically ill patients.

Molfino A, Alessandri F, Mosillo P, Dell'Utri D, Farcomeni A, Amabile MI, Laviano A.

Clin Nutr. 2018 Dec;37(6 Pt A):2186-2190. doi: 10.1016/j.clnu.2017.10.021. Epub 2017 Nov 4.

PMID:
29154111
18.

Magnetic Resonance Imaging after Breast Oncoplastic Surgery: An Update.

Gigli S, Amabile MI, Di Pastena F, Manganaro L, David E, Monti M, DʼOrazi V, Catalano C, Ballesio L.

Breast Care (Basel). 2017 Sep;12(4):260-265. doi: 10.1159/000477896. Epub 2017 Aug 10. Review.

19.

Anti-catabolic neurohormonal blockade to improve skeletal muscle during disease.

Molfino A, Amabile MI, Muscaritoli M.

Expert Opin Biol Ther. 2017 Dec;17(12):1583. doi: 10.1080/14712598.2017.1392029. Epub 2017 Oct 23. No abstract available.

PMID:
29019426
20.

Corrigendum: Effect of Underlying Renal Disease on Nutritional and Metabolic Profile of Older Adults with Reduced Renal Function.

Lai S, Amabile MI, Altieri S, Mastroluca D, Lai C, Aceto P, Crudo M, D'Angelo AR, Muscaritoli M, Molfino A.

Front Nutr. 2017 Oct 4;4:44. doi: 10.3389/fnut.2017.00044. eCollection 2017.

21.

Lipofilling Outcomes Mimicking Breast Cancer Recurrence: Case Report and Update of the Literature.

Gigli S, Amabile MI, DI Pastena F, DE Luca A, Gulia C, Manganaro L, Monti M, Ballesio L.

Anticancer Res. 2017 Oct;37(10):5395-5398. Review.

PMID:
28982848
22.

Effect of Oral Docosahexaenoic Acid (DHA) Supplementation on DHA Levels and Omega-3 Index in Red Blood Cell Membranes of Breast Cancer Patients.

Molfino A, Amabile MI, Mazzucco S, Biolo G, Farcomeni A, Ramaccini C, Antonaroli S, Monti M, Muscaritoli M.

Front Physiol. 2017 Jul 28;8:549. doi: 10.3389/fphys.2017.00549. eCollection 2017.

23.

Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?

Molfino A, Amabile MI, Monti M, Muscaritoli M.

Oxid Med Cell Longev. 2017;2017:5987082. doi: 10.1155/2017/5987082. Epub 2017 Jun 14. Review.

24.

Effect of Underlying Renal Disease on Nutritional and Metabolic Profile of Older Adults with Reduced Renal Function.

Lai S, Amabile MI, Altieri S, Mastroluca D, Lai C, Aceto P, Crudo M, D'Angelo AR, Muscaritoli M, Molfino A.

Front Nutr. 2017 Mar 17;4:4. doi: 10.3389/fnut.2017.00004. eCollection 2017. Erratum in: Front Nutr. 2017 Oct 04;4:44.

25.

The metabolite beta-aminoisobutyric acid and physical inactivity among hemodialysis patients.

Molfino A, Amabile MI, Ammann T, Farcomeni A, Lionetto L, Simmaco M, Lai S, Laviano A, Rossi Fanelli F, Chiappini MG, Muscaritoli M.

Nutrition. 2017 Feb;34:101-107. doi: 10.1016/j.nut.2016.07.012. Epub 2016 Jul 30.

PMID:
28063504
26.

Plasma Cell Mastitis in Men: A Single-center Experience and Review of the Literature.

Palmieri A, D'Orazi V, Martino G, Frusone F, Crocetti D, Amabile MI, Monti M.

In Vivo. 2016 11-12;30(6):727-732. Review.

PMID:
27815454
27.

Oncoplastic central quadrantectomies.

Pasta V, D'Orazi V, Merola R, Frusone F, Amabile MI, De Luca A, Buè R, Monti M.

Gland Surg. 2016 Aug;5(4):422-6. doi: 10.21037/gs.2016.04.01. Review.

28.

Foods and their components promoting gastrointestinal cancer.

Muscaritoli M, Amabile MI, Molfino A.

Curr Opin Clin Nutr Metab Care. 2016 Sep;19(5):377-381. doi: 10.1097/MCO.0000000000000309.

PMID:
27389082
29.

Novel therapeutic options for cachexia and sarcopenia.

Molfino A, Amabile MI, Rossi Fanelli F, Muscaritoli M.

Expert Opin Biol Ther. 2016 Oct;16(10):1239-44. doi: 10.1080/14712598.2016.1208168. Epub 2016 Jul 11. Review.

PMID:
27382931
30.

Wire-guided Localization in Non-palpable Breast Cancer: Results from Monocentric Experience.

Tardioli S, Ballesio L, Gigli S, DI Pastena F, D'Orazi V, Giraldi G, Monti M, Amabile MI, Pasta V.

Anticancer Res. 2016 May;36(5):2423-7.

PMID:
27127152
31.

The Role of Docosahexaenoic Acid (DHA) in the Control of Obesity and Metabolic Derangements in Breast Cancer.

Molfino A, Amabile MI, Monti M, Arcieri S, Rossi Fanelli F, Muscaritoli M.

Int J Mol Sci. 2016 Apr 5;17(4):505. doi: 10.3390/ijms17040505. Review.

32.

Nipple-sparing Mastectomy in Patients with Preoperative Diagnosis of Non-invasive Breast Carcinoma. A Single-center Experience.

Amabile MI, Monti M, Merola R, Frusone F, D'Orazi V, Pasta V.

Anticancer Res. 2016 Feb;36(2):779-83.

PMID:
26851039
33.

Carnitine for the treatment of cachexia: Lights and shadows.

Molfino A, Amabile MI, Monti M, Rossi Fanelli F, Muscaritoli M.

Int J Cardiol. 2015 Nov 1;198:180-1. doi: 10.1016/j.ijcard.2015.06.156. Epub 2015 Jul 2. No abstract available.

PMID:
26163913
34.

Factors Predictive of Re-excision After Oncoplastic Breast-conserving Surgery.

Amabile MI, Mazouni C, Guimond C, Sarfati B, Leymarie N, Cloutier AS, Bentivegna E, Garbay JR, Kolb F, Rimareix F.

Anticancer Res. 2015 Jul;35(7):4229-34.

PMID:
26124383
35.

Quilting Sutures Reduces Seroma in Mastectomy.

Mazouni C, Mesnard C, Cloutier AS, Amabile MI, Bentivegna E, Garbay JR, Sarfati B, Leymarie N, Kolb F, Rimareix F.

Clin Breast Cancer. 2015 Aug;15(4):289-93. doi: 10.1016/j.clbc.2014.12.014. Epub 2015 Jan 9.

PMID:
25661806
36.

TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.

Bartucci M, Dattilo R, Moriconi C, Pagliuca A, Mottolese M, Federici G, Benedetto AD, Todaro M, Stassi G, Sperati F, Amabile MI, Pilozzi E, Patrizii M, Biffoni M, Maugeri-Saccà M, Piccolo S, De Maria R.

Oncogene. 2015 Feb 5;34(6):681-90. doi: 10.1038/onc.2014.5. Epub 2014 Feb 17.

PMID:
24531710
37.

Metal-on-metal hip prostheses: correlation between debris in the synovial fluid and levels of cobalt and chromium ions in the bloodstream.

De Pasquale D, Stea S, Squarzoni S, Bordini B, Amabile M, Catalani S, Apostoli P, Toni A.

Int Orthop. 2014 Mar;38(3):469-75.

38.

Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia.

Arpinati M, Tolomelli G, Bochicchio MT, Castagnetti F, Amabile M, Bandini G, Bonifazi F, Stanzani M, Rosti G, Martinelli G, Baccarani M.

Biol Blood Marrow Transplant. 2013 May;19(5):735-40. doi: 10.1016/j.bbmt.2013.01.007. Epub 2013 Jan 17.

39.

Breast sarcoma in a pregnant patient A case report.

Pasta V, Amabile MI, Bizzarri M, Monti M.

Ann Ital Chir. 2012 Sep 28;2012. pii: S2239253X12020178.

PMID:
23070281
40.

Personal technique for treatment of perianal fistulas in outpatients.

Pasta V, Redler A, Amabile MI, Merola R, Monti M.

Ann Ital Chir. 2012 May-Jun;83(3):269-72.

PMID:
22595737
41.

Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party.

Gugliotta G, Castagnetti F, Palandri F, Breccia M, Intermesoli T, Capucci A, Martino B, Pregno P, Rupoli S, Ferrero D, Gherlinzoni F, Montefusco E, Bocchia M, Tiribelli M, Pierri I, Grifoni F, Marzocchi G, Amabile M, Testoni N, Martinelli G, Alimena G, Pane F, Saglio G, Baccarani M, Rosti G; Gruppo Italiano Malattie Ematologiche dell'Adulto CML Working Party.

Blood. 2011 May 26;117(21):5591-9. doi: 10.1182/blood-2010-12-324228. Epub 2011 Mar 30.

PMID:
21450900
42.

Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis.

Marzocchi G, Castagnetti F, Luatti S, Baldazzi C, Stacchini M, Gugliotta G, Amabile M, Specchia G, Sessarego M, Giussani U, Valori L, Discepoli G, Montaldi A, Santoro A, Bonaldi L, Giudici G, Cianciulli AM, Giacobbi F, Palandri F, Pane F, Saglio G, Martinelli G, Baccarani M, Rosti G, Testoni N; Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) Working Party on Chronic Myeloid Leukemia.

Blood. 2011 Jun 23;117(25):6793-800. doi: 10.1182/blood-2011-01-328294. Epub 2011 Mar 29.

PMID:
21447834
43.

Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis.

Soverini S, Vitale A, Poerio A, Gnani A, Colarossi S, Iacobucci I, Cimino G, Elia L, Lonetti A, Vignetti M, Paolini S, Meloni G, di Maio V, Papayannidis C, Amabile M, Guarini A, Baccarani M, Martinelli G, Foà R.

Haematologica. 2011 Apr;96(4):552-7. doi: 10.3324/haematol.2010.034173. Epub 2010 Dec 29.

44.

[Comparison of plasma matrix metalloproteases 2, 3, 9 in breast carcinomas and fibroadenomas].

Solai F, Nardo T, Patrizi G, Annessi M, Santulli M, Amabile MI, Vasaturo F.

G Chir. 2010 Aug-Sep;31(8-9):365-7. Italian.

PMID:
20843437
45.

Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis.

Castagnetti F, Testoni N, Luatti S, Marzocchi G, Mancini M, Kerim S, Giugliano E, Albano F, Cuneo A, Abruzzese E, Martino B, Palandri F, Amabile M, Iacobucci I, Alimena G, Pane F, Martinelli G, Saglio G, Baccarani M, Rosti G.

J Clin Oncol. 2010 Jun 1;28(16):2748-54. doi: 10.1200/JCO.2009.26.7963. Epub 2010 May 3.

PMID:
20439635
46.

The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase.

Palandri F, Castagnetti F, Iacobucci I, Martinelli G, Amabile M, Gugliotta G, Poerio A, Testoni N, Breccia M, Bocchia M, Crugnola M, Rege-Cambrin G, Martino B, Pierri I, Radaelli F, Specchia G, Pane F, Saglio G, Rosti G, Baccarani M.

Haematologica. 2010 Aug;95(8):1415-9. doi: 10.3324/haematol.2009.021246. Epub 2010 Mar 19.

47.

Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib.

Lemoli RM, Salvestrini V, Bianchi E, Bertolini F, Fogli M, Amabile M, Tafuri A, Salati S, Zini R, Testoni N, Rabascio C, Rossi L, Martin-Padura I, Castagnetti F, Marighetti P, Martinelli G, Baccarani M, Ferrari S, Manfredini R.

Blood. 2009 Dec 10;114(25):5191-200. doi: 10.1182/blood-2008-08-176016.

PMID:
19855080
48.

Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemia.

Rosti G, Palandri F, Castagnetti F, Breccia M, Levato L, Gugliotta G, Capucci A, Cedrone M, Fava C, Intermesoli T, Cambrin GR, Stagno F, Tiribelli M, Amabile M, Luatti S, Poerio A, Soverini S, Testoni N, Martinelli G, Alimena G, Pane F, Saglio G, Baccarani M; GIMEMA CML Working Party.

Blood. 2009 Dec 3;114(24):4933-8. doi: 10.1182/blood-2009-07-232595. Epub 2009 Oct 12.

PMID:
19822896
49.

Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP.

Testoni N, Marzocchi G, Luatti S, Amabile M, Baldazzi C, Stacchini M, Nanni M, Rege-Cambrin G, Giugliano E, Giussani U, Abruzzese E, Kerim S, Grimoldi MG, Gozzetti A, Crescenzi B, Carcassi C, Bernasconi P, Cuneo A, Albano F, Fugazza G, Zaccaria A, Martinelli G, Pane F, Rosti G, Baccarani M.

Blood. 2009 Dec 3;114(24):4939-43. doi: 10.1182/blood-2009-07-229864. Epub 2009 Oct 1.

PMID:
19797518
50.

Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure.

Palandri F, Castagnetti F, Soverini S, Poerio A, Gugliotta G, Luatti S, Amabile M, Martinelli G, Rosti G, Baccarani M.

Haematologica. 2009 Dec;94(12):1758-61. doi: 10.3324/haematol.2009.010496. Epub 2009 Jul 16.

Supplemental Content

Loading ...
Support Center